UNIVERSAL TECHNICAL INSTITUT (UTI) Stock Fundamental Analysis
USA - NYSE:UTI - US9139151040 - Common Stock
29.79 USD
+0.14 (+0.47%)
30.3 USD
+0.51 (+1.71%)
Taking everything into account, UTI scores 6 out of 10 in our fundamental rating. UTI was compared to 78 industry peers in the Diversified Consumer Services industry. UTI has an excellent profitability rating, but there are some minor concerns on its financial health. UTI is growing strongly while it is still valued neutral. This is a good combination! This makes UTI very considerable for growth investing!
1. Profitability
1.1 Basic Checks
UTI had positive earnings in the past year.
In the past year UTI had a positive cash flow from operations.
In the past 5 years UTI has always been profitable.
UTI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of UTI (8.52%) is better than 78.21% of its industry peers.
UTI's Return On Equity of 20.57% is amongst the best of the industry. UTI outperforms 85.90% of its industry peers.
The Return On Invested Capital of UTI (10.86%) is better than 84.62% of its industry peers.
The Average Return On Invested Capital over the past 3 years for UTI is below the industry average of 9.61%.
The last Return On Invested Capital (10.86%) for UTI is above the 3 year average (5.11%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.52% | ||
| ROE | 20.57% | ||
| ROIC | 10.86% |
ROA(3y)2.68%
ROA(5y)2.09%
ROE(3y)7.52%
ROE(5y)5.81%
ROIC(3y)5.11%
ROIC(5y)N/A
1.3 Margins
UTI has a Profit Margin of 7.79%. This is in the better half of the industry: UTI outperforms 69.23% of its industry peers.
In the last couple of years the Profit Margin of UTI has grown nicely.
UTI's Operating Margin of 10.44% is fine compared to the rest of the industry. UTI outperforms 67.95% of its industry peers.
In the last couple of years the Operating Margin of UTI has grown nicely.
Looking at the Gross Margin, with a value of 49.65%, UTI is in line with its industry, outperforming 55.13% of the companies in the same industry.
In the last couple of years the Gross Margin of UTI has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 10.44% | ||
| PM (TTM) | 7.79% | ||
| GM | 49.65% |
OM growth 3Y21.82%
OM growth 5YN/A
PM growth 3Y23.23%
PM growth 5YN/A
GM growth 3Y-14.8%
GM growth 5Y-8.67%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so UTI is still creating some value.
The number of shares outstanding for UTI has been increased compared to 1 year ago.
Compared to 5 years ago, UTI has more shares outstanding
UTI has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.87 indicates that UTI is not in any danger for bankruptcy at the moment.
UTI has a better Altman-Z score (3.87) than 84.62% of its industry peers.
UTI has a debt to FCF ratio of 0.99. This is a very positive value and a sign of high solvency as it would only need 0.99 years to pay back of all of its debts.
UTI has a Debt to FCF ratio of 0.99. This is amongst the best in the industry. UTI outperforms 84.62% of its industry peers.
UTI has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.23, UTI perfoms like the industry average, outperforming 57.69% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 0.99 | ||
| Altman-Z | 3.87 |
ROIC/WACC1.28
WACC8.48%
2.3 Liquidity
UTI has a Current Ratio of 1.00. This is a normal value and indicates that UTI is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.00, UTI perfoms like the industry average, outperforming 44.87% of the companies in the same industry.
A Quick Ratio of 1.00 indicates that UTI should not have too much problems paying its short term obligations.
UTI has a Quick ratio of 1.00. This is comparable to the rest of the industry: UTI outperforms 50.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 128.00% over the past year.
UTI shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 28.35% yearly.
Looking at the last year, UTI shows a quite strong growth in Revenue. The Revenue has grown by 14.56% in the last year.
UTI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 17.19% yearly.
EPS 1Y (TTM)128%
EPS 3Y28.35%
EPS 5YN/A
EPS Q2Q%111.11%
Revenue 1Y (TTM)14.56%
Revenue growth 3Y29.79%
Revenue growth 5Y17.19%
Sales Q2Q%15.12%
3.2 Future
UTI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.50% yearly.
Based on estimates for the next years, UTI will show a quite strong growth in Revenue. The Revenue will grow by 10.46% on average per year.
EPS Next Y44.42%
EPS Next 2Y12.22%
EPS Next 3Y12.5%
EPS Next 5YN/A
Revenue Next Year14.42%
Revenue Next 2Y11.29%
Revenue Next 3Y10.46%
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 26.13, which means the current valuation is very expensive for UTI.
The rest of the industry has a similar Price/Earnings ratio as UTI.
When comparing the Price/Earnings ratio of UTI to the average of the S&P500 Index (26.35), we can say UTI is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 31.97, the valuation of UTI can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UTI is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 33.72. UTI is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.13 | ||
| Fwd PE | 31.97 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, UTI is valued a bit cheaper than the industry average as 60.26% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of UTI indicates a somewhat cheap valuation: UTI is cheaper than 65.38% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.69 | ||
| EV/EBITDA | 12.53 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of UTI may justify a higher PE ratio.
A more expensive valuation may be justified as UTI's earnings are expected to grow with 12.50% in the coming years.
PEG (NY)0.59
PEG (5Y)N/A
EPS Next 2Y12.22%
EPS Next 3Y12.5%
5. Dividend
5.1 Amount
No dividends for UTI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
29.79
+0.14 (+0.47%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)
Earnings (Next)
Inst Owners94.48%
Inst Owner Change2.29%
Ins Owners2.24%
Ins Owner Change-1.76%
Market Cap1.62B
Revenue(TTM)809.53M
Net Income(TTM)63.10M
Analysts81.82
Price Target38.18 (28.16%)
Short Float %3.62%
Short Ratio2.71
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.03
Dividend Growth(5Y)-34.43%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)71.27%
Min EPS beat(2)69.26%
Max EPS beat(2)73.27%
EPS beat(4)4
Avg EPS beat(4)69.47%
Min EPS beat(4)12.21%
Max EPS beat(4)123.12%
EPS beat(8)7
Avg EPS beat(8)80.23%
EPS beat(12)10
Avg EPS beat(12)129.78%
EPS beat(16)14
Avg EPS beat(16)215.22%
Revenue beat(2)2
Avg Revenue beat(2)2.83%
Min Revenue beat(2)1.15%
Max Revenue beat(2)4.51%
Revenue beat(4)4
Avg Revenue beat(4)2.54%
Min Revenue beat(4)1.15%
Max Revenue beat(4)4.51%
Revenue beat(8)8
Avg Revenue beat(8)2.39%
Revenue beat(12)11
Avg Revenue beat(12)2.98%
Revenue beat(16)15
Avg Revenue beat(16)3.43%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-1.46%
EPS NQ rev (3m)-21%
EPS NY rev (1m)-0.31%
EPS NY rev (3m)1.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.6%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 26.13 | ||
| Fwd PE | 31.97 | ||
| P/S | 2 | ||
| P/FCF | 21.69 | ||
| P/OCF | 15.04 | ||
| P/B | 5.28 | ||
| P/tB | 6.22 | ||
| EV/EBITDA | 12.53 |
EPS(TTM)1.14
EY3.83%
EPS(NY)0.93
Fwd EY3.13%
FCF(TTM)1.37
FCFY4.61%
OCF(TTM)1.98
OCFY6.65%
SpS14.88
BVpS5.64
TBVpS4.79
PEG (NY)0.59
PEG (5Y)N/A
Graham Number12.02
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.52% | ||
| ROE | 20.57% | ||
| ROCE | 15.21% | ||
| ROIC | 10.86% | ||
| ROICexc | 13.78% | ||
| ROICexgc | 15.4% | ||
| OM | 10.44% | ||
| PM (TTM) | 7.79% | ||
| GM | 49.65% | ||
| FCFM | 9.23% |
ROA(3y)2.68%
ROA(5y)2.09%
ROE(3y)7.52%
ROE(5y)5.81%
ROIC(3y)5.11%
ROIC(5y)N/A
ROICexc(3y)7.05%
ROICexc(5y)N/A
ROICexgc(3y)7.97%
ROICexgc(5y)N/A
ROCE(3y)7.15%
ROCE(5y)N/A
ROICexgc growth 3Y41.64%
ROICexgc growth 5YN/A
ROICexc growth 3Y37.09%
ROICexc growth 5YN/A
OM growth 3Y21.82%
OM growth 5YN/A
PM growth 3Y23.23%
PM growth 5YN/A
GM growth 3Y-14.8%
GM growth 5Y-8.67%
F-Score6
Asset Turnover1.09
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 0.99 | ||
| Debt/EBITDA | 0.58 | ||
| Cap/Depr | 87.82% | ||
| Cap/Sales | 4.08% | ||
| Interest Coverage | 11.6 | ||
| Cash Conversion | 88.25% | ||
| Profit Quality | 118.43% | ||
| Current Ratio | 1 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 3.87 |
F-Score6
WACC8.48%
ROIC/WACC1.28
Cap/Depr(3y)259.47%
Cap/Depr(5y)259.17%
Cap/Sales(3y)10.54%
Cap/Sales(5y)10.62%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)128%
EPS 3Y28.35%
EPS 5YN/A
EPS Q2Q%111.11%
EPS Next Y44.42%
EPS Next 2Y12.22%
EPS Next 3Y12.5%
EPS Next 5YN/A
Revenue 1Y (TTM)14.56%
Revenue growth 3Y29.79%
Revenue growth 5Y17.19%
Sales Q2Q%15.12%
Revenue Next Year14.42%
Revenue Next 2Y11.29%
Revenue Next 3Y10.46%
Revenue Next 5YN/A
EBIT growth 1Y85.69%
EBIT growth 3Y58.11%
EBIT growth 5YN/A
EBIT Next Year114.2%
EBIT Next 3Y30.39%
EBIT Next 5YN/A
FCF growth 1Y395.38%
FCF growth 3YN/A
FCF growth 5Y32.12%
OCF growth 1Y222.73%
OCF growth 3Y15.89%
OCF growth 5Y31.61%
UNIVERSAL TECHNICAL INSTITUT / UTI FAQ
What is the fundamental rating for UTI stock?
ChartMill assigns a fundamental rating of 6 / 10 to UTI.
Can you provide the valuation status for UNIVERSAL TECHNICAL INSTITUT?
ChartMill assigns a valuation rating of 4 / 10 to UNIVERSAL TECHNICAL INSTITUT (UTI). This can be considered as Fairly Valued.
Can you provide the profitability details for UNIVERSAL TECHNICAL INSTITUT?
UNIVERSAL TECHNICAL INSTITUT (UTI) has a profitability rating of 7 / 10.
What are the PE and PB ratios of UNIVERSAL TECHNICAL INSTITUT (UTI) stock?
The Price/Earnings (PE) ratio for UNIVERSAL TECHNICAL INSTITUT (UTI) is 26.13 and the Price/Book (PB) ratio is 5.28.
Can you provide the expected EPS growth for UTI stock?
The Earnings per Share (EPS) of UNIVERSAL TECHNICAL INSTITUT (UTI) is expected to grow by 44.42% in the next year.